The revised EVOLVE 2030 approach improves Chemours' (CC) ability to integrate its business processes with this goal.
WILMINGTON, Del., June 05, 2024--The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Shane Hostetter as Chief Financial Officer (CFO) effective July 1, 2024. As CFO, Shane will lead Finance, Investor Relations, Corporate Development, Strategy, and Enterprise Risk Management.
WILMINGTON, Del., June 04, 2024--Chemours Enhances EVOLVE 2030 Portfolio Sustainability Assessment Methodology